Form 8-K - Current report:
SEC Accession No. 0001104659-23-017612
Filing Date
2023-02-09
Accepted
2023-02-09 16:30:39
Documents
12
Period of Report
2023-02-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm236017d1_8k.htm   iXBRL 8-K 28744
  Complete submission text file 0001104659-23-017612.txt   203322

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nrbo-20230208.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrbo-20230208_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrbo-20230208_pre.xml EX-101.PRE 22605
6 EXTRACTED XBRL INSTANCE DOCUMENT tm236017d1_8k_htm.xml XML 3619
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 23606686
SIC: 2834 Pharmaceutical Preparations